Skip to search formSkip to main contentSkip to account menu

MSH Release-Inhibiting Hormone

Known as: Prol-Leu-Gly-NH2, Melanocyte-Stimulating Hormone Release-Inhibiting Hormone, MIF-I 
A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
A consistent pattern of changes in the 31P MR spectra of normal premenopausal breast during the menstrual cycle has been obser… 
1987
1987
Complex interactions of the pituitary, hypothalamus, and pineal involving MIF-1 (Pro-Leu-Gly-NH2) were shown many years ago. One… 
1985
1985
The effect of chronic administration of morphine to Sprague-Dawley rats on the binding of dopamine receptor agonist, 3H-N-n… 
1984
1984
A lixiviacao de Ca, K e Mg sob irrigacao foi avaliada em um Latossolo Vermelho-Escuro, pelo uso de capsulas porosas, durante o… 
1979
1979
The conformations of melanostatin have been studied experimentally using CD spectroscopy and via calculations. In aqueous… 
1978
1978
Five of 8 patients with unipolar or bipolar endogenous depressions taking prolyl-leucyl-glycinamide (MIF-I), 75 mg/day, showed… 
1977
1977
The regulation of release of MSH and ACTH seems to be closely related. The effect of Pro-Leu-Gly-NH2, the most active MSH-release… 
1977
1977
The intracarotid injection of both synthetic melanocyte-stimulating hormone release-inhibiting factor (MIF) and purified MIF… 
1975
1975
1-Deamino-4-glu-oxytocin (1-beta-mercaptopropionic acid-4-glutamic acid - oxytocin) was synthesized by sequential reduction by… 
Highly Cited
1972
Highly Cited
1972
Summary MIF was demonstrated to antagonize the central and peripheral effects of oxotremorine in normal as well as in…